Other · developed by Prothena Biosciences
PRX019 is an investigational drug studied in Healthy Participants Study.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT06699680 | Phase 1 | Healthy Participants Study | Completed | PRTA |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Healthy Participants Study
Updated Oct 25, 2026. Something wrong or missing? Report it on the PRTA page.
See PRTA's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
PRTA catalysts and pipeline →